Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Heliyon
|
September 16, 2024
Safety profile of levonorgestrel intrauterine system: Analysis of spontaneous reports submitted to FAERS
Lin Chen, Rui Bao, Xiaojiang Tian
Expert Opinion on Drug Safety
|
February 20, 2025
Adverse event profiles of CDK4/6 inhibitors: a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database
Xiaojiang Tian, Lin Chen, Yonghong Chen, et al.
Scientific Reports
|
August 13, 2025
Quantum granular-ball generation methods and their application in KNN classification
Suzhen Yuan, Xiaojiang Tian, Wenping Lin, et al.
Frontiers in Pharmacology
|
April 11, 2022
Adverse Event Profiles of PARP Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS
Xiaojiang Tian, Lin Chen, Di Gai, et al.
Scientific Reports
|
June 15, 2021
Systematic analysis of safety profile for darunavir and its boosted agents using data mining in the FDA Adverse Event Reporting System database
Xiaojiang Tian, Yao Yao, Guanglin He, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Heliyon
|
September 16, 2024
Safety profile of levonorgestrel intrauterine system: Analysis of spontaneous reports submitted to FAERS
Lin Chen, Rui Bao, Xiaojiang Tian
Expert Opinion on Drug Safety
|
February 20, 2025
Adverse event profiles of CDK4/6 inhibitors: a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database
Xiaojiang Tian, Lin Chen, Yonghong Chen, et al.
Scientific Reports
|
August 13, 2025
Quantum granular-ball generation methods and their application in KNN classification
Suzhen Yuan, Xiaojiang Tian, Wenping Lin, et al.
Frontiers in Pharmacology
|
April 11, 2022
Adverse Event Profiles of PARP Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS
Xiaojiang Tian, Lin Chen, Di Gai, et al.
Scientific Reports
|
June 15, 2021
Systematic analysis of safety profile for darunavir and its boosted agents using data mining in the FDA Adverse Event Reporting System database
Xiaojiang Tian, Yao Yao, Guanglin He, et al.
Page
of 1